Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.

Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, Peng X.

Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.

2.

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC.

Krentz Gober M, Collard JP, Thompson K, Black EP.

Sci Rep. 2017 Jun 23;7(1):4202. doi: 10.1038/s41598-017-04097-7.

3.

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.

Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, Lendermon JB, Bheemreddy R, Zhang Q, Brennan RC, Johnson D, Steinle JJ, Wilson MW, Morales-Tirado VM.

BMC Cancer. 2017 Jun 20;17(1):434. doi: 10.1186/s12885-017-3418-y.

4.

Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information.

Horejs CM, St-Pierre JP, Ojala JRM, Steele JAM, da Silva PB, Rynne-Vidal A, Maynard SA, Hansel CS, Rodríguez-Fernández C, Mazo MM, You AYF, Wang AJ, von Erlach T, Tryggvason K, López-Cabrera M, Stevens MM.

Nat Commun. 2017 Jun 8;8:15509. doi: 10.1038/ncomms15509.

5.

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status.

Hayashi N, Iwamoto T, Qi Y, Niikura N, Santarpia L, Yamauchi H, Nakamura S, Hortobagyi GN, Pusztai L, Symmans WF, Ueno NT.

J Cancer. 2017 Apr 9;8(6):1045-1052. doi: 10.7150/jca.13690. eCollection 2017.

6.

Immunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma.

Tamaki T, Shimizu T, Niki M, Shimizu M, Nishizawa T, Nomura S.

Oncol Lett. 2017 May;13(5):3695-3702. doi: 10.3892/ol.2017.5864. Epub 2017 Mar 16.

7.

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.

Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.

Oncol Rep. 2017 Jun;37(6):3189-3200. doi: 10.3892/or.2017.5583. Epub 2017 Apr 19.

8.

Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition.

Xu S, Jiang B, Wang H, Shen C, Chen H, Zeng L.

Evid Based Complement Alternat Med. 2017;2017:7876064. doi: 10.1155/2017/7876064. Epub 2017 Jan 22.

9.

TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation.

Nakano N, Tsuchiya Y, Kako K, Umezaki K, Sano K, Ikeno S, Otsuka E, Shigeta M, Nakagawa A, Sakata N, Itoh F, Nakano Y, Iemura SI, van Dinther M, Natsume T, Ten Dijke P, Itoh S.

J Biol Chem. 2017 Mar 10;292(10):4099-4112. doi: 10.1074/jbc.M116.769109. Epub 2017 Jan 23.

PMID:
28115518
10.

Epithelial-mesenchymal transition in tumor metastasis.

Yeung KT, Yang J.

Mol Oncol. 2017 Jan;11(1):28-39. doi: 10.1002/1878-0261.12017. Epub 2016 Dec 9. Review.

11.

Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).

Tang Z, Li J, Shen Q, Feng J, Liu H, Wang W, Xu L, Shi G, Ye X, Ge M, Zhou X, Ni S.

Int J Cancer. 2017 Apr 1;140(7):1620-1632. doi: 10.1002/ijc.30571. Epub 2017 Feb 2.

12.

Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Martínez-Ramírez AS, Díaz-Muñoz M, Butanda-Ochoa A, Vázquez-Cuevas FG.

Purinergic Signal. 2017 Mar;13(1):1-12. doi: 10.1007/s11302-016-9550-3. Epub 2016 Nov 29. Review.

13.

Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.

Schaefer L, Tredup C, Gubbiotti MA, Iozzo RV.

FEBS J. 2017 Jan;284(1):10-26. doi: 10.1111/febs.13963. Epub 2016 Dec 7. Review.

PMID:
27860287
14.

TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.

Kawarada Y, Inoue Y, Kawasaki F, Fukuura K, Sato K, Tanaka T, Itoh Y, Hayashi H.

Sci Rep. 2016 Oct 19;6:35483. doi: 10.1038/srep35483.

15.

Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells.

Lu X, Guo H, Chen X, Xiao J, Zou Y, Wang W, Chen Q.

Oncol Rep. 2016 Dec;36(6):3105-3112. doi: 10.3892/or.2016.5146. Epub 2016 Oct 4.

16.

ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.

Hashimoto A, Hashimoto S, Sugino H, Yoshikawa A, Onodera Y, Handa H, Oikawa T, Sabe H.

Oncogenesis. 2016 Sep 12;5(9):e259. doi: 10.1038/oncsis.2016.60.

17.

Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell.

Li D, Sun H, Sun WJ, Bao HB, Si SH, Fan JL, Lin P, Cui RJ, Pan YJ, Wen SM, Zheng XL, Yu XG.

Oncotarget. 2016 Oct 4;7(40):65553-65567. doi: 10.18632/oncotarget.11549.

18.

The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis.

Lebrun JJ.

ISRN Mol Biol. 2012 Dec 24;2012:381428. doi: 10.5402/2012/381428. eCollection 2012. Review.

19.

Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response.

Kwon OS, Kim KT, Lee E, Kim M, Choi SH, Li H, Fornace AJ Jr, Cho JH, Lee YS, Lee JS, Lee YJ, Cha HJ.

PLoS One. 2016 May 12;11(5):e0154942. doi: 10.1371/journal.pone.0154942. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0160137.

20.

Identification and characterization of an hnRNP E1 translational silencing motif.

Brown AS, Mohanty BK, Howe PH.

Nucleic Acids Res. 2016 Jul 8;44(12):5892-907. doi: 10.1093/nar/gkw241. Epub 2016 Apr 11.

Supplemental Content

Support Center